Breaking news

Why the UAE Is Becoming A Premier Destination For Medical Tourism

With a commitment to enhancing its healthcare offerings, the UAE has positioned itself as a leader in medical tourism, catering to a growing global demand. As countries focus on improving the health of their populations, the UAE stands out for its strategic investments in both healthcare infrastructure and its appeal to medical tourists.

According to Statista, the global medical tourism market was valued at $47 billion in 2024, with projections indicating it could exceed $111 billion by 2029. The UAE is setting the bar high, with innovative initiatives such as specialized portals for health tourists and streamlined entry processes for medical visitors.

Tailored Portals And Seamless Experiences

Abu Dhabi and Dubai have launched dedicated online platforms that streamline the process for medical tourists. These portals offer a range of services, including healthcare provider contact information, appointment bookings, hotel reservations, and local transportation. Dubai Health Authority (DHA) introduced the Dubai Health Experience (DXH) brand in 2016, aimed at making the city a global leader in health tourism. The platform offers a curated selection of top-tier treatments in fields such as dentistry, fertility, ophthalmology, and cosmetic surgery.

Meanwhile, in 2018, Abu Dhabi’s Department of Health (DoH) rolled out its own e-portal, showcasing a network of over 40 healthcare facilities that meet the stringent quality standards of the DoH’s JAWDA program. Visitors can explore nearly 300 treatment packages across specialties ranging from routine check-ups to complex surgeries.

Simplified Access With Specialized Permits

To further attract international patients, the UAE offers specialized entry permits for medical tourists and their companions. These permits, which can be single or multiple entries, are sponsored by medical institutions and processed by relevant authorities in the country. Dubai Healthcare City also introduced a new medical visa in January 2024, allowing treatment centers to apply for permits on behalf of patients for stays of up to six months. This move bolsters Dubai’s reputation as a medical tourism hotspot.

The city welcomed 674,000 medical tourists in 2022, generating $270 million in revenue. Wellness tourism is also booming in the UAE, with visitors spending $5.4 billion in 2022—almost double the amount spent in 2020.

Innovation At The Forefront

The UAE’s innovative spirit continues to propel its rise as a medical tourism hub. In 2024, HealthStay.io, the world’s first AI-powered medical tourism solution, launched in partnership with Dubai Health Experience. This startup, part of the Mohammed Bin Rashid Innovation Fund’s Accelerator Program, uses artificial intelligence to automate the medical tourism journey, including selecting treatments and booking appointments.

“The launch of HealthStay.io is a direct result of the support from DXH and DHA, helping us transform Dubai into a global healthcare tourism leader,” said Ruairi Tubrid, co-founder of HealthStay.io. Fatima Yousif Alnaqbi, MBRIF representative, emphasized the importance of accelerator programs in supporting innovative solutions that elevate the UAE’s standing as a center of excellence in healthcare.

Government Commitment To Healthcare Excellence

The UAE’s rapid growth in medical tourism is rooted in its consistent focus on healthcare improvement. Key strategies such as the Emirates Health Services Innovation Strategy 2023-2026 and the National Strategy for Wellbeing 2031 aim to enhance residents’ quality of life and elevate the nation’s healthcare offerings.

Compared to its Gulf Cooperation Council (GCC) counterparts, the UAE leads in healthcare expenditure growth. Projections from Alpen Capital estimate that healthcare spending will reach $30.7 billion by 2027, reflecting the nation’s ongoing dedication to strengthening its healthcare infrastructure. As a result, the UAE continues to attract international patients seeking top-tier medical services.

Dell’s Earnings Beat Puts The AI Trade To The Test

Dell Technologies has become a key stock to watch after its latest earnings report strengthened the case for continued AI infrastructure spending but failed to trigger a sustained rally.

Shares jumped more than 13% after Tuesday’s opening bell before giving back much of the gain. By late morning Wednesday, the stock was up about 5%, raising questions about whether strong AI-related earnings are still enough to drive higher valuations.

Strong Results Meet A More Skeptical Market

The reaction echoes last week’s trading in Nvidia. Its shares climbed nearly 9% after strong quarterly results and a stronger long-term outlook, only to surrender much of the advance in subsequent sessions.

That pattern has encouraged some investors to reduce exposure to AI stocks. Strong results remain evident, but markets appear less willing to reward them with sustained valuation expansion.

Dell Raises 2027 Earnings Outlook

Three months ago, Dell shares surged almost 33% after the company raised its fiscal 2027 adjusted earnings-per-share guidance by 39%. Analysts followed by lifting their own estimates, while the stock retained most of its gains.

This time, Dell raised fiscal 2027 earnings guidance to $25.50 from $17.90, an increase of about 42.5%. Street consensus rose nearly 29% overnight, yet the stock was up only about 5% in Wednesday trading.

The weaker share-price reaction suggests investors are applying a more cautious valuation to Dell than they did in May.

AI Exposure Faces Greater Caution

We have been raising cash for the Club as the AI trade has become more volatile and less predictable. Tuesday’s decision to exit Corning increased our cash position to about 15%.

If capital is redeployed, it would likely favor more defensive areas outside AI. That reflects greater caution over valuations and positioning rather than a rejection of the AI investment theme.

Dell’s Trading Could Set The Tone

A further rise in Dell shares would suggest investors remain willing to increase AI exposure, while a flat performance would point to greater valuation discipline. A decline could indicate that much of the earnings upside is already priced in.

Dell’s report, along with Broadcom’s results due Wednesday evening, could still improve sentiment across the group. If investors continue to discount strong AI earnings, however, the case for a more defensive approach will strengthen.

For now, Dell offers a real-time test of whether strong AI-related earnings can continue to drive valuations higher as investor caution increases.

Uol
eCredo
The Future Forbes Realty Global Properties
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter